Arun J Sanyal (A J Sanyal, Arun Sanyal)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 82

Top Venues

Nature medicine

Alimentary pharmacology & therapeutics

Hepatology communications

Hepatology (Baltimore, Md.)

Virginia Commonwealth University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Virginia Commonwealth University Jul 01 1990

United States

Professor of Medicine :: Internal medicine

Publications

Nicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, Mulugeta Saneshaw, Michael O Idowu, Amy L Olex, Arun J Sanyal, Masoud H Manjili
Effective anti-tumor immune response against HCC is orchestrated by immune cell partnership network that functions through hepatic homeostatic pathways, not direct cytotoxicity. bioRxiv : the preprint server for biology (2024)
Janani S Iyer, Dinkar Juyal, Quang Le, Zahil Shanis, Harsha Pokkalla, Maryam Pouryahya, Aryan Pedawi, S Adam Stanford-Moore, Charles Biddle-Snead, Oscar Carrasco-Zevallos, Mary Lin, Robert Egger, Sara Hoffman, Hunter Elliott, Kenneth Leidal, Robert P Myers, Chuhan Chung, Andrew N Billin, Timothy R Watkins, Scott D Patterson, Murray Resnick, Katy Wack, Jon Glickman, Alastair D Burt, Rohit Loomba, Arun J Sanyal, Ben Glass, Michael C Montalto, Amaro Taylor-Weiner, Ilan Wapinski, Andrew H Beck
AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases. Nature medicine (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine 30 (7) (2024)
Elliot B Tapper, David S Goldberg, Neehar D Parikh, Norah A Terrault, Nicole Welch, Suzanne Sharpton, Bilal Hameed, Mandana Khalili, Andrew A Stolz, Elizabeth C Verna, Robert S Brown, Arun J Sanyal, Lisa B Van Wagner, Daniela P Ladner, Cynthia A Moylan, Anna Mae Diehl, Patricia D Jones, Stephen Caldwell, Srinivasan Dasarathy, Douglas A Simonetto, Vijay H Shah, Jasmohan Singh Bajaj, null null
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. The American journal of gastroenterology (2024)
Kavish R Patidar, Wanzhu F Tu, Thomas Gerard Cotter, Douglas A Simonetto, Amon Asgharpour, Muhammad Y Jan, Qing Tang, Yunpeng Yu, Yang Li, Moyinoluwa Taiwo, Prashanth Thevkar Nagesh, Srinivasan Dasarathy, Patrick S Kamath, Craig J McClain, Naga Chalasani, Gyongyi Szabo, Ramon Bataller, Mack C Mitchell, Wajahat Z Mehal, Laura E Nagy, Vijay H Shah, Samer Gawrieh, Arun J Sanyal, null null
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology (Baltimore, Md.) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics (2024)
Siew S Lim, Zhila Semnani-Azad, Mario Luca Morieri, Ashley H Ng, Abrar Ahmad, Hugo Fitipaldi, Jacqueline Boyle, Christian Collin, Raphael Sonabend, Claudia Langenberg, Ruth J F Loos, Melinda Morrison, Michelle Ramsay, Arun J Sanyal, Naveed Sattar, Marie-France Hivert, Maria F Gomez, Ruth J F Loos, Deirdre K Tobias, Michael I Trenell, Stephen S Rich, Jennifer L Sargent, Paul W Franks
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist. Nature medicine 30 (7) (2024)
Nikolai V Naoumov, David E Kleiner, Elaine Chng, Dominique Brees, Chandrassegar Saravanan, Yayun Ren, Dean Tai, Arun J Sanyal
Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology. Liver international : official journal of the International Association for the Study of the Liver (2024)
Kavish R Patidar, Wanzhu F Tu, Thomas Gerard Cotter, Douglas A Simonetto, Amon Asgharpour, Muhammad Y Jan, Qing Tang, Yunpeng Yu, Yang Li, Moyinoluwa Taiwo, Prashanth Thevkar Nagesh, Srinivasan Dasarathy, Patrick S Kamath, Craig J McClain, Naga Chalasani, Gyongyi Szabo, Ramon Bataller, Mack C Mitchell, Wajahat Z Mehal, Laura E Nagy, Vijay H Shah, Samer Gawrieh, Arun J Sanyal, null null
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology (Baltimore, Md.) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine (2024)
Hai-Yang Yuan, Xiao-Fei Tong, Ya-Yun Ren, Yang-Yang Li, Xin-Lei Wang, Li-Li Chen, Sui-Dan Chen, Xiao-Zhi Jin, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Lai Wei, Vincent W-S Wong, Dean Tai, Arun J Sanyal, Hong You, Ming-Hua Zheng
AI-based digital pathology provides newer insights into lifestyle intervention-induced fibrosis regression in MASLD: An exploratory study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine 30 (7) (2024)
Bani Mukhopadhyay, Cheryl Marietta, Pei-Hong Shen, Abdul Oiseni, Faridoddin Mirshahi, Maria Mazzu, Colin Hodgkinson, Eli Winkler, Qiaoping Yuan, Daniel Miranda, George Kunos, Arun J Sanyal, David Goldman
A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis. Nature communications 15 (1) (2024)
Faiez Zannad, Arun J Sanyal, Javed Butler, Veronica Miller, Stephen A Harrison
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease. Nature medicine (2024)
Nicholas Koelsch, Faridoddin Mirshahi, Hussein F Aqbi, Mulugeta Saneshaw, Michael O Idowu, Amy L Olex, Arun J Sanyal, Masoud H Manjili
Effective anti-tumor immune response against HCC is orchestrated by immune cell partnership network that functions through hepatic homeostatic pathways, not direct cytotoxicity. bioRxiv : the preprint server for biology (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine 30 (7) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Naga P Chalasani, Eduardo Vilar-Gomez, Stephen Caldwell, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah A Terrault, Laura A Wilson, James Tonascia, Arun J Sanyal
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine (2024)
Bani Mukhopadhyay, Cheryl Marietta, Pei-Hong Shen, Abdul Oiseni, Faridoddin Mirshahi, Maria Mazzu, Colin Hodgkinson, Eli Winkler, Qiaoping Yuan, Daniel Miranda, George Kunos, Arun J Sanyal, David Goldman
A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis. Nature communications 15 (1) (2024)
Vlad Ratziu, Yusuf Yilmaz, Don Lazas, Scott L Friedman, Caroline Lackner, Cynthia Behling, Oscar W Cummings, Li Chen, Mathieu Petitjean, Yossi Gilgun-Sherki, Tali Gorfine, Shaul Kadosh, Eli Eyal, Arun J Sanyal
Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology. Hepatology (Baltimore, Md.) (2024)
Elliot B Tapper, David S Goldberg, Neehar D Parikh, Norah A Terrault, Nicole Welch, Suzanne Sharpton, Bilal Hameed, Mandana Khalili, Andrew A Stolz, Elizabeth C Verna, Robert S Brown, Arun J Sanyal, Lisa B Van Wagner, Daniela P Ladner, Cynthia A Moylan, Anna Mae Diehl, Patricia D Jones, Stephen Caldwell, Srinivasan Dasarathy, Douglas A Simonetto, Vijay H Shah, Jasmohan Singh Bajaj, null null
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. The American journal of gastroenterology (2024)
Bani Mukhopadhyay, Cheryl Marietta, Pei-Hong Shen, Abdul Oiseni, Faridoddin Mirshahi, Maria Mazzu, Colin Hodgkinson, Eli Winkler, Qiaoping Yuan, Daniel Miranda, George Kunos, Arun J Sanyal, David Goldman
A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis. Nature communications 15 (1) (2024)
Theodore T Pierce, Arinc Ozturk, Sarah P Sherlock, Guilherme Moura Cunha, Xiaohong Wang, Qian Li, David Hunt, Michael S Middleton, Marian Martin, Kathleen E Corey, Hannah Edenbaum, Sudha S Shankar, Helen Heymann, Tania N Kamphaus, Roberto A Calle, Yesenia Covarrubias, Stephen Caldwell, Nancy A Obuchowski, Arun J Sanyal, Claude B Sirlin, Kathryn J Fowler, Anthony E Samir
Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease. Radiology 312 (3) (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine 30 (7) (2024)
Arun J Sanyal, Lee M Kaplan, Juan P Frias, Bram Brouwers, Qiwei Wu, Melissa K Thomas, Charles Harris, Nanette C Schloot, Yu Du, Kieren J Mather, Axel Haupt, Mark L Hartman
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nature medicine (2024)
Siew S Lim, Zhila Semnani-Azad, Mario Luca Morieri, Ashley H Ng, Abrar Ahmad, Hugo Fitipaldi, Jacqueline Boyle, Christian Collin, Raphael Sonabend, Claudia Langenberg, Ruth J F Loos, Melinda Morrison, Michelle Ramsay, Arun J Sanyal, Naveed Sattar, Marie-France Hivert, Maria F Gomez, Ruth J F Loos, Deirdre K Tobias, Michael I Trenell, Stephen S Rich, Jennifer L Sargent, Paul W Franks
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist. Nature medicine 30 (7) (2024)
Kavish R Patidar, Wanzhu F Tu, Thomas Gerard Cotter, Douglas A Simonetto, Amon Asgharpour, Muhammad Y Jan, Qing Tang, Yunpeng Yu, Yang Li, Moyinoluwa Taiwo, Prashanth Thevkar Nagesh, Srinivasan Dasarathy, Patrick S Kamath, Craig J McClain, Naga Chalasani, Gyongyi Szabo, Ramon Bataller, Mack C Mitchell, Wajahat Z Mehal, Laura E Nagy, Vijay H Shah, Samer Gawrieh, Arun J Sanyal, null null
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone. Hepatology (Baltimore, Md.) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Manuel Romero, Matthew James Armstrong, Jesús Funuyet-Salas, Kamal Kant Mangla, Steen Ladelund, Anne-Sophie Sejling, Ichhya Shrestha, Arun J Sanyal
Editorial: Feeling better about NASH-Authors' reply. Alimentary pharmacology & therapeutics 58 (4) (2023)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Arun J Sanyal, Prakash Jha, David E Kleiner
Digital pathology for nonalcoholic steatohepatitis assessment. Nature reviews. Gastroenterology & hepatology (2023)
Philip Noel Newsome, Arun J Sanyal, Guy Neff, Jörn Markus Schattenberg, Vlad Ratziu, Judith Ertle, Jasmin Link, Alison Mackie, Corinna Schoelch, Eric Lawitz, null null
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis. Nature communications 14 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Sudha S Shankar, Katherine P Yates, James Bolognese, Erika Daly, Clayton A Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj K Vuppalanchi, Cynthia Behling, James Tonascia, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock, Kathryn Fowler, Helen Heymann, Tania N Kamphaus, Stephen Caldwell, Roberto A Calle
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis. Nature medicine (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Kathryn J Fowler, Sudhakar K Venkatesh, Nancy Obuchowski, Michael S Middleton, Jun Chen, Kay Pepin, Jessica Magnuson, Kathy J Brown, Danielle Batakis, Walter C Henderson, Sudha S Shankar, Tania N Kamphaus, Alex Pasek, Roberto A Calle, Arun J Sanyal, Rohit Loomba, Richard L Ehman, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock
Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium. Radiology 309 (1) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine (2023)
Pojsakorn Danpanichkul, Cheng-Han Ng, Mark Dhinesh Muthiah, Kwanjit Duangsonk, Jie Ning Yong, Darren Jun Hao Tan, Wen Hui Lim, Zhen Yu Wong, Nicholas Li-Xun Syn, Tsubasa Tsusumi, Hirokazu Takahashi, Mohammad Shadab Siddiqui, Vincent Wai-Sun Wong, Christos S Mantzoros, Daniel Q Huang, Mazen Noureddin, Rohit Loomba, Arun J Sanyal, Karn Wijarnpreecha
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary pharmacology & therapeutics (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Manuel Romero, Matthew James Armstrong, Jesús Funuyet-Salas, Kamal Kant Mangla, Steen Ladelund, Anne-Sophie Sejling, Ichhya Shrestha, Arun J Sanyal
Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trial. Alimentary pharmacology & therapeutics (2023)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Arun J Sanyal, Jérémy Magnanensi, Zouher Majd, Christian Rosenquist, Delphis M Vera, James P Almas, Margery A Connelly
NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older. Hepatology communications 7 (9) (2023)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Chunqing Guo, Wenjie Liu, Zheng Liu, Jinyang Cai, Xiaofei Yu, Hongxia Wang, Xia Li, Daming Zuo, Xixian Jiang, Bei Zhang, Jinze Liu, Arun J Sanyal, Puneet Puri, Huiping Zhou, Xiang-Yang Wang
Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury. Hepatology (Baltimore, Md.) (2023)
Melissa Palmer, David E Kleiner, Zachary Goodman, Elizabeth Brunt, Mark I Avigan, Arie Regev, Paul H Hayashi, James H Lewis, Ruby Mehta, Stephen A Harrison, Massimo Siciliano, Charles A McWherter, Raj K Vuppalanchi, Cynthia Behling, Veronica Miller, Naga P Chalasani, Arun J Sanyal
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary pharmacology & therapeutics (2023)
Ryan M Gill, Daniela Allende, Patricia H Belt, Cynthia A Behling, Oscar W Cummings, Cynthia D Guy, Daniela Carpenter, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Mark L Van Natta, Laura A Wilson ScM, Goro Yamada, Matthew M Yeh, David E Kleiner, null null
The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance. Hepatology communications 7 (2) (2023)
Chunqing Guo, Wenjie Liu, Zheng Liu, Jinyang Cai, Xiaofei Yu, Hongxia Wang, Xia Li, Daming Zuo, Xixian Jiang, Bei Zhang, Jinze Liu, Arun J Sanyal, Puneet Puri, Huiping Zhou, Xiang-Yang Wang
Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury. Hepatology (Baltimore, Md.) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Patricia Lopez, Eric J Lawitz, Kathryn J Lucas, Juergen Loeffler, Won Kim, George B B Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M Sheikh, John M Vierling, Yoon Jun Kim, Hideyuki Hyogo, Dean Tai, Zachary Goodman, Felicity Schaefer, Ian R I Carbarns, Sophie Lamle, Miljen Martic, Nikolai V Naoumov, Clifford A Brass
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial. Nature medicine 29 (2) (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Florence S H Wong, Stephen Chris Pappas, Rajender K Reddy, Hugo Vargas, Michael P Curry, Arun J Sanyal, Khurram Jamil
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Alimentary pharmacology & therapeutics 56 (8) (2022)
Jieling Xiao, Cheng-Han Ng, Yip-Han Chin, Darren Jun Hao Tan, Wen-Hui Lim, Grace Lim, Jingxuan Quek, Ansel Shao Pin Tang, Kai-En Chan, Rou-Yi Soong, Nicholas W S Chew, Benjamin Tay, Daniel Q Huang, Nobuharu Tamaki, Roger Sik Yin Foo, Mark Yan-Yee Chan, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Dhinesh Muthiah
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia. Journal of clinical and translational hepatology 10 (6) (2022)
Cheng-Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Clarissa Elysia Fu, Ansel Shao Pin Tang, Lay Hoon Goh, Kamala Devi, Nicholas W S Chew, Lung-Yi Loey Mak, Nobuharu Tamaki, Daniel Q Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mark Dhinesh Muthiah
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives. Alimentary pharmacology & therapeutics 56 (4) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. Alimentary pharmacology & therapeutics 56 (1) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga P Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell, null null
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 55 (11) (2022)
Arun J Sanyal, Sudha S Shankar, Roberto A Calle, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock, Stephen Caldwell, Kathryn J Fowler, Clayton A Dehn, Helen Heymann, Tania N Kamphaus
Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project. Nature medicine 28 (3) (2022)
Cheng-Han Ng, Mark Dhinesh Muthiah, Jieling Xiao, Yip Han Chin, Grace Lim, Wen Hui Lim, Phoebe Tay, Darren Jun Hao Tan, Jie Ning Yong, Xin-Hui Pan, Jeffery Wei Heng Koh, Nicholas Chew, Nicholas Li-Xun Syn, Eunice Tan, Daniel Q Huang, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mazen Noureddin
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis. Alimentary pharmacology & therapeutics 55 (9) (2022)
Vlad Ratziu, L de Guevara, R Safadi, F Poordad, F Fuster, J Flores-Figueroa, M Arrese, Anna L Fracanzani, D Ben Bashat, K Lackner, T Gorfine, S Kadosh, R Oren, M Halperin, L Hayardeny, Stephen Caldwell, Scott L Friedman, null null, Arun J Sanyal
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nature medicine 27 (10) (2021)
Raj Vuppalanchi, Mazen Noureddin, Naim Alkhouri, Arun J Sanyal
Therapeutic pipeline in nonalcoholic steatohepatitis. Nature reviews. Gastroenterology & hepatology 18 (6) (2021)
Richard K Sterling, Dongho Shin, Yongyun Shin, Evan French, Michael P Stevens, Jasmohan Singh Bajaj, Marjolein DeWit, Arun J Sanyal
Fibrosis-4 Predicts the Need for Mechanical Ventilation in a National Multiethnic Cohort of Corona Virus Disease 2019. Hepatology communications 5 (9) (2021)
Somaya A M Albhaisi, Arun J Sanyal
New drugs for NASH. Liver international : official journal of the International Association for the Study of the Liver (2021)
Hannah P Kim, Michael O Idowu, Andrea R Mospan, Andrew G Allmon, Michael Roden, Philip Newsome, Anna S Lok, Paul J Thuluvath, Jawahar Taunk, Michael W Fried, Arun J Sanyal, Alfred Sidney Barritt, null null
Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis. Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Ana Carolina Cardoso, Claudio de Figueiredo-Mendes, Cristiane Alves Villela Nogueira, Arun J Sanyal
New drugs for non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Mark Dhinesh Muthiah, Arun J Sanyal
Current management of non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver (2021)
Margery A Connelly, Jonathan Velez Rivera, John R Guyton, Mohammad Shadab Siddiqui, Arun J Sanyal
Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics 52 (4) (2020)
Stephen Caldwell, Lei Ling, Duy M Dinh, Alex M DePaoli, Hsiao D Lieu, Stephen A Harrison, Arun J Sanyal
The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. Hepatology (Baltimore, Md.) 73 (1) (2020)
Arun J Sanyal, Vaishali Patel, Arun J Sanyal
Future therapy for non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2019)
Arie Regev, Melissa Palmer, Mark I Avigan, Lara Dimick-Santos, William R Treem, John F Marcinak, Daniel Seekins, Gopal Krishna, Frank A Anania, James W Freston, James H Lewis, Arun J Sanyal, Naga Chalasani
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 49 (6) (2019)
Niharika R Samala, Samer Gawrieh, Qing Tang, Spencer G Lourens, Vijay H Shah, Arun J Sanyal, Suthat Liangpunsakul, Naga Chalasani
Clinical Characteristics and Outcomes of Mild to Moderate Alcoholic Hepatitis. GastroHep 1 (4) (2019)
Philip Noel Newsome, Sven Francque, Stephen Harrison, Vlad Ratziu, Luc Van Gaal, Salvatore Calanna, Morten Hansen, Martin Linder, Arun J Sanyal
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Alimentary pharmacology & therapeutics 50 (2) (2019)
Naga Chalasani, Manal F Abdelmalek, Rohit Loomba, Kris V Kowdley, Arthur J McCullough, Srinivasan Dasarathy, Brent A Neuschwander-Tetri, Norah Terrault, Beatrice Ferguson, Reshma Shringarpure, David Shapiro, Arun J Sanyal
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis. Liver international : official journal of the International Association for the Study of the Liver 39 (5) (2019)
Arun J Sanyal, T D Boyer, R T Frederick, F Wong, L Rossaro, V Araya, H E Vargas, K R Reddy, S C Pappas, P Teuber, S Escalante, K Jamil
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Alimentary pharmacology & therapeutics 45 (11) (2017)

Arun J Sanyal.css-eqlu8i{font-size:small;padding-left:4px;} (A J Sanyal, Arun Sanyal)

Publication Activity (10 Years)

Top Topics

Top Venues

Arun J Sanyal (A J Sanyal, Arun Sanyal)